Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Refractory to Lenalidomide (PCP)

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Fondazione Neoplasie Sangue Onlus

ClinicalTrials.gov Identifier:

NCT01166113

First received: July 16, 2010

Last updated: February 5, 2016

Last verified: February 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	July 2018
Primary Completion Date:	June 2011 (Final data collection date for primary outcome measure)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):